Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tianling Chen

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Seminars in Oncology|June 13, 2003
EPO906 (epothilone B): a promising novel microtubule stabilizerJohn Rothermel, Markus Wartmann, Tianling Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2009
CAT-8015: a second-generation pseudomonas exotoxin A-based immunotherapy targeting CD22-expressing hematologic malignanciesRalph F Alderson, Robert J Kreitman, Tianling Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 23, 2005
Phase I dose-finding study of weekly single-agent patupilone in patients with advanced solid tumorsEric H Rubin, John Rothermel, Fisseha Tesfaye, et al.
Plos One|May 26, 2022
Effect of early mobilization combined with early nutrition on acquired weakness in critically ill patients (EMAS): A dual-center, randomized controlled trialWendie Zhou, Lili Yu, Yuying Fan, et al.
Ejhaem|May 19, 2023
A phase 1 first-in-human study of GS-0189, an anti-signal regulatory protein alpha (SIRPα) monoclonal antibody, in patients with relapsed/refractory (R/R) non-Hodgkin lymphoma (NHL)Mayur Narkhede, Nancy L Bartlett, Sami Ibrahimi, et al.
Journal of Nanobiotechnology|January 1, 2025
Mesoporous Prussian blue nanoparticle neuroconduit for the biological therapy targeting oxidative stress reduction, inflammation inhibition, and nerve regenerationJunyi Zhu, Yijia Zhang, Yinuo Sun, et al.
Journal of Clinical Pharmacology|November 5, 2002
Pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone metastasesTianling Chen, James Berenson, Robert Vescio, et al.
Journal of Advanced Research|April 5, 2025
Natural, safety immunomodulatory derivatives of lactobacillus biofilms promote diabetic wound healing by metabolically regulating macrophage phenotype and alleviating local inflammationQingwei Zhou, Junjie Chi, Jintao Yang, et al.
ACS Biomaterials Science & Engineering|June 17, 2024
Acid Neutralization by Composite Lysine Nanoparticles for Spinal Cord Injury Recovery through Mitigating Mitochondrial DysfunctionQiuchen Wang, Lu Ge, Jiali Guo, et al.
Journal for Immunotherapy of Cancer|February 6, 2023
Phase 1 first-in-human study of dalutrafusp alfa, an anti-CD73-TGF-β-trap bifunctional antibody, in patients with advanced solid tumorsAnthony W Tolcher, Michael Gordon, Kathleen M Mahoney, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Seminars in Oncology|June 13, 2003
EPO906 (epothilone B): a promising novel microtubule stabilizerJohn Rothermel, Markus Wartmann, Tianling Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2009
CAT-8015: a second-generation pseudomonas exotoxin A-based immunotherapy targeting CD22-expressing hematologic malignanciesRalph F Alderson, Robert J Kreitman, Tianling Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 23, 2005
Phase I dose-finding study of weekly single-agent patupilone in patients with advanced solid tumorsEric H Rubin, John Rothermel, Fisseha Tesfaye, et al.
Plos One|May 26, 2022
Effect of early mobilization combined with early nutrition on acquired weakness in critically ill patients (EMAS): A dual-center, randomized controlled trialWendie Zhou, Lili Yu, Yuying Fan, et al.
Ejhaem|May 19, 2023
A phase 1 first-in-human study of GS-0189, an anti-signal regulatory protein alpha (SIRPα) monoclonal antibody, in patients with relapsed/refractory (R/R) non-Hodgkin lymphoma (NHL)Mayur Narkhede, Nancy L Bartlett, Sami Ibrahimi, et al.
Journal of Nanobiotechnology|January 1, 2025
Mesoporous Prussian blue nanoparticle neuroconduit for the biological therapy targeting oxidative stress reduction, inflammation inhibition, and nerve regenerationJunyi Zhu, Yijia Zhang, Yinuo Sun, et al.
Journal of Clinical Pharmacology|November 5, 2002
Pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone metastasesTianling Chen, James Berenson, Robert Vescio, et al.
Journal of Advanced Research|April 5, 2025
Natural, safety immunomodulatory derivatives of lactobacillus biofilms promote diabetic wound healing by metabolically regulating macrophage phenotype and alleviating local inflammationQingwei Zhou, Junjie Chi, Jintao Yang, et al.
ACS Biomaterials Science & Engineering|June 17, 2024
Acid Neutralization by Composite Lysine Nanoparticles for Spinal Cord Injury Recovery through Mitigating Mitochondrial DysfunctionQiuchen Wang, Lu Ge, Jiali Guo, et al.
Journal for Immunotherapy of Cancer|February 6, 2023
Phase 1 first-in-human study of dalutrafusp alfa, an anti-CD73-TGF-β-trap bifunctional antibody, in patients with advanced solid tumorsAnthony W Tolcher, Michael Gordon, Kathleen M Mahoney, et al.
Pageof 2